250
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

IL-12 receptor 1β deficiency with features of autoimmunity and photosensitivity

, , , , , & show all
Pages 143-146 | Received 15 Oct 2015, Accepted 16 Dec 2015, Published online: 13 Jan 2016

References

  • Ochs, H., and D. Hagin. 2014. Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment. Ann. Allergy Asthma Immunol. 112: 489–495
  • Cunningham-Rundles, C. 2011. Autoimmunity in primary immune deficiency: taking lessons from our patients. Clin. Exp. Immunol. 164: 6–11
  • Croxford, A., P. Kulig, and B. Becher.2014. IL-12 and IL-23 in health and disease. Cytokine Growth Factor Rev. 25: 415–421
  • Doffinger, R., S. Patel, and D. Kumararatne. 2005. Human immunodeficiencies that predispose to intracellular bacterial infections. Curr. Opin. Rheumatol. 17: 440–446
  • Petri, M., A. Orbai, G. Alarcon, et al. 2012. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arth. Rheum. 64: 2677–2686
  • Dolff, S., M. Bijl, M. Huitema, et al. 2011. Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus. Clin. Immunol. 141: 197–204
  • Horwitz, D., J. D. Gray, S. Behrendsen, et al. 1998. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arth. Rheum. 31: 838–844
  • Huang, X., J. Hua, and S. Chen. 2007. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients. Mod. Rheumatol. 17: 220–223
  • McCarthy, E., S. Smith, R. Lee, et al. 2014. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. Rheumatol (Oxford). 53: 1586–1594
  • Westerberg, L., C. Klein, and S. Snapper. 2008. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency – lessons learned from monogenic disorders in mice and men. Curr. Opin. Immunol. 20: 646–654
  • Arandi, A., A. Mirshafiey, H. Abolhassani, et al. 2013. Frequency and expression of inhibitory markers of CD4+CD25+FoxP3+ regulatory T cells in patients with common variable immunodeficiency. Scand. J. Immunol. 281: 129–133
  • Shevach, E., and A. Thomton. 2014. tTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259: 88–102
  • Verma, N., B. Hall, K. Plain, et al. 2014. Interleukin-12 (IL-12p70) promotes induction of highly potent Th1-like CD4+CD25+ T regulatory cells that inhibit allograft rejection in unmodified recipients. Frontiers Immunol. 5: 190. doi: 10.3389/fimmu.2014.00190
  • Ichihashi, M., M. Ueda, A. Budiyanto, et al. 2003. UV-induced skin damage. Toxicology. 189: 21–39
  • Schwarz, A., S. Grabbe, Y. Aragane, et al. 1996. Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. J. Invest. Dermatol. 106: 1187–1191
  • Kavanaugh, A., D. Solomon, and The American College of Rheumatology Ad Hoc Committee on Immulogical Testing Guidelines. 2002. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arth. Rheum. 47: 546–555
  • Koike, T., H. Tomioka, and A. Kumagai. 1982. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 50: 298–302
  • Airoldi, I., E. Di Carlo, C. Cocco, et al. 2005. Lack of Il12rβ2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood. 106: 3846–3853

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.